Wednesday, February, 20, 2019 11:58:26

Contribution By Ojaswita Kutepatil


argenx & Halozyme ink global collaboration & license agreement

Antibody therapeutic developer argenx and Halozyme Therapeutics, Inc. have reportedly announced a collaboration and license agreement that would enable the former to utilize Halozyme’s ENHANZE® drug delivery technology. Sources claim that argenx would be liable to use ENHANZE to generate subcutaneous product formulations for argenx’s …

Goldman Sachs & HSBC back UK fintech startup Bud with $20M investment

The two global banking organizations entered the fintech startup’s series A funding round for the investment.  The funding round also saw participants such as Australia’s ANZ, Spain’s Banco Sabadell and Investec alongside other investors. Renowned American investment banking firm, Goldman Sachs and British financial services …